SMI falls 0.43% by midday as Novartis weighs
Published on 11/19/2026 at 13:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSMI under pressure by midday
- The SMI stood at 14,822.38 points at 12:38 CET on Thursday, down 0.43% from Wednesday's close.
- Novartis, Nestle, Swiss Re, Sika and Givaudan were among the weaker constituents, while Logitech, Richemont and ABB gained.
- European equities opened higher in the morning, with technology shares supported by renewed interest in artificial intelligence stocks.
The SMI was trading at 14,822.38 points at 12:38 CET on Thursday, November 19, according to finanzen.ch. That put the Swiss blue-chip index 63.74 points, or 0.43%, below Wednesday's close of 14,886.12 points. The SMI had opened at 14,889.47 points and remained below that level around midday.
Defensive shares lead the decline
Market leadership was divided. Novartis was among the weakest SMI constituents, down 2.78% at the time of the midday reading. Nestle fell 1.57%, Swiss Re declined 1.43%, Sika lost 1.19% and Givaudan was 0.86% lower. The moves placed pressure on the index despite gains elsewhere in the benchmark.
Logitech was among the strongest performers, rising 2.65%, while Richemont gained 2.34% and ABB advanced 2.18%. UBS was up 0.83% and Amrize added 0.71%. The distribution of gains and losses pointed to a mixed session beneath the index-level decline rather than a uniform move across all constituents.
European markets opened broadly higher
In the morning, the SMI had been among the weaker major European benchmarks. A market update from The Edge placed the index at 14,869.42 points at 09:03 GMT, equivalent to 10:03 CET, down 0.11% against Wednesday's close. Most other European indices were higher at that stage, led by the FTSE MIB and Euro Stoxx 50.
The Edge linked the broader European morning rebound to renewed interest in artificial-intelligence stocks after Anthropic's share sale. Technology was the strongest of the sector gauges tracked in that early market reading. That support was not enough to lift the SMI by midday, as losses in several large healthcare, consumer and financial names outweighed advances in selected technology and luxury stocks.
Index structure remains concentrated
SIX describes the SMI as the benchmark for Switzerland's blue-chip equity market. The index comprises 20 of the largest and most liquid equities from the SPI and covers about 75% of Swiss equity-market capitalization, according to the SIX overview. As a result, pronounced moves in major healthcare and consumer holdings can have a substantial effect on the overall index.
Further reports are available on the SMI topic page.
